Stein, R. C., Makris, A., Macpherson, I. R., Hughes-Davies, L., Marshall, A., Pinder, S. E., Shaaban, A., Taylor, K. J., Conefrey, C., Falzon, M. R., Naume, B., Kiely, B. E., Cameron, D. A., Earl, H. M., Rea, D. W., Hall, P. S., Morgan, A., McIntosh, S., Bartlett, J. M., Dunn, J. (2026). First results from the OPTIMA phase III randomized non-inferiority trial of test-directed chemotherapy in patients with high clinical risk ER-positive HER2-negative early breast cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.500